このエントリーをはてなブックマークに追加
ID 51298
file
k8525_1.pdf 91.2 KB
k8525_2.pdf 173 KB
k8525_4.pdf 1.42 MB
title alternative
間質性肺疾患合併肺癌患者における細胞障害性抗癌剤による薬剤性肺障害の予測マーカーとしてのHMGB1の有用性
creator
Nakao, Satoshi
description
内容の要約
language
eng
nii type
Thesis or Dissertation
HU type
Doctoral Theses
DCMI type
text
format
application/pdf
rights
(c) 2020 This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/.
This is not the published version. Please cite only the published version. この論文は出版社版ではありません。引用の際には出版社版をご確認、ご利用ください。
relation
Satoshi Nakao, Kakuhiro Yamaguchi, Hiroshi Iwamoto, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori, Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease, Respiratory Medicine, Volume 172, 2020, 106131
relation url
grantid
甲第8525号
degreeGrantor
広島大学(Hiroshima University)
degreename Ja
博士(医学)
degreename En
Doctor of Philosophy in Medical Science
degreelevel
doctoral
date of granted
2021-03-23
department
Graduate School of Biomedical & Health Sciences